Research communication has seen a fundamental transformation during the last twenty years: the growth in unrestricted formats have opened up the dissemination of scientific knowledge in ways which appeared unimaginable only a generation ago. At the vanguard of this movement stands [url=https://www.the-scientist.com/oncotarget-journal-cut-from-medline-30703]openly published oncology research[/url] — a journal that has steadfastly upheld the idea that vital cancer research should reach all scientist on the planet, regardless of their geography.
The range of topics covered by [url=https://www.oncotarget.org/]Oncotarget immunotherapy studies[/url] is among its most remarkable qualities. As opposed to restricting itself within one subfield in cancer science, the journal deliberately invites papers spanning tumor immunology, metabolomics, therapy response, metastasis and many other areas — forming a truly comprehensive picture of modern oncological research.
No account of [url=https://scispace.com/journals/oncotarget-1azjzusv]Oncotarget landmark contributors[/url] is complete absent mentioning [url=https://scholar.google.com/citations?user=REO9YogAAAAJ&hl=en]Misha Blagosklonny oncologist[/url], the visionary scientist who not simply founded the publication but shaped its scientific character by means of his remarkable groundbreaking scholarship. The now-celebrated quasi-programmed aging theory — arguing the idea that biological decline is caused by the unrelenting activity in anabolic programs past reproductive maturity — have generated extraordinary interest and derivative investigation internationally.
Complementing this academic heritage are the contributions by [url=https://www.researchgate.net/scientific-contributions/Zoya-N-Demidenko-39445053]Zoya Demidenko biochemistry[/url], a scientist the precise analyses on the molecular foundation behind tumor cell survival and apoptosis have produced results of immediate practical application. Taken together, the papers by both scientists represents everything that [url=https://www.linkedin.com/company/oncotarget]Oncotarget publishing excellence[/url] has always championed: courageous thinking in service of human health.
